Výsledky vyhledávání - "Keiko Kawaguchi"

Akademický článek

A Study of Universal Design for Household Budget Management of Multiple Debtors: Perspectives from Those Who Have Difficulty Coping. (English)

Autor: Mika Tokumura, Keiko Kawaguchi

Publikováno v: Journal of Japan Academy of Consumer Education; 2024, Vol. 44, p93-102, 10p

Zobrazit plný text záznamu

Sensitivity of a transcription-mediated amplification method (Aptima Mycoplasma genitalium assay) to detect M. genitalium in vitro

Autor: Ryoichi Hamasuna, Naohiro Fujimoto, Hisami Aono, Keiko Kawaguchi, Masahiro Matsumoto

Publikováno v: Journal of Infection and Chemotherapy. 27:573-577

Introduction Mycoplasma genitalium is a known causative pathogen for some sexually transmitted infections. Nucleic acid amplification tests are a recommended method for detecting M. genitalium. A transcription-mediated amplification (TMA) nucleic aci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acd657b38e21fd3a52271174b715d105
https://doi.org/10.1016/j.jiac.2020.11.010

Zobrazit plný text záznamu

Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial

Autor: Frederick G. Hayden, Takeki Uehara, Simon Portsmouth, Takao Shishido, Kenji Tsuchiya, Masahiro Kinoshita, Toru Ishibashi, Keiko Kawaguchi

Publikováno v: Journal of the Pediatric Infectious Diseases Society

Background Baloxavir marboxil has demonstrated safety and efficacy in treating adult and adolescent outpatients with acute influenza (CAPSTONE-1 trial). Here, we report a subgroup analysis of outcomes in adolescents from the trial. Methods CAPSTONE-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a7667cd8940d8411af722595019a6a
https://doi.org/10.1093/jpids/piaa145

Zobrazit plný text záznamu

Baloxavir marboxil for prophylaxis against influenza in household contacts

Autor: Takeki Uehara, Frederick G. Hayden, Keiko Kawaguchi, Takeshi Noshi, Nelson Lee, Menno D. de Jong, Kenji Tsuchiya, Hideyuki Ikematsu, Masahiro Kinoshita, Satoru Takashima

Publikováno v: New England journal of medicine, 383(4), 309-320. Massachussetts Medical Society

BACKGROUND Baloxavir marboxil (baloxavir) is a polymerase acidic protein (PA) endonuclease inhibitor with clinical efficacy in the treatment of uncomplicated influenza, including in outpatients at increased risk for complications. The postexposure pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51fc08e15c1630ffb46c8ca4a2b24af9
https://doi.org/10.1056/nejmoa1915341

Zobrazit plný text záznamu

Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza

Autor: Simon Portsmouth, Takeki Uehara, Nelson Lee, Keiko Kawaguchi, Takao Shishido, Frederick G. Hayden, Keiko Baba, Nobuo Hirotsu, Norio Sugaya, Shinya Omoto, Menno D. de Jong, Hiroshi Kida, Kenji Tsuchiya, Aeron C. Hurt

Publikováno v: J Infect Dis
Journal of infectious diseases, 221(3), 346-355. Oxford University Press

BackgroundSingle-dose baloxavir rapidly reduces influenza virus titers and symptoms in patients with uncomplicated influenza, but viruses with reduced in vitro susceptibility due to amino acid substitutions at position 38 of polymerase acidic protein

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97357011d81e2eedc4deee297ff0f7ee
https://doi.org/10.1093/infdis/jiz244

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání